Ignyta Raises $5.5M in Series B Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Autoimmune molecular diagnostics firm Ignyta said this week that it has raised $5.5 million in an expanded Series B equity financing round.

Additionally, the firm received a $500,000 capital term loan in June 2012 from Silicon Valley Bank bringing the total in Series B-related proceeds to $6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.